A study aimed to investigate the role of the SET-NUP214 fusion gene in measuring residual disease (MRD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute leukemia. The gene discussed is SET; the disease is acute leukemia.